Solara Active Pharma Sciences Ltd

Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby confirm that we have uploaded audio recording of the Q4 of FY23 Earnings Call held on May 12 2023 on our Company website under the heading Investor relations/Stock Exchange Communication/ Investor update.